NeuroPace, Inc. vs Sight Sciences, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- NeuroPace, Inc. is the larger company by market value: $487 M against $448 M for Sight Sciences, Inc., 1.1 times as much (market caps of Sep 18, 2026 for NeuroPace, Inc. and Aug 1, 2026 for Sight Sciences, Inc.). NeuroPace, Inc.'s value is the last on file, from Sep 18, 2026: no market-data feed is connected for its exchange yet. Sight Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- NeuroPace, Inc. had more revenue: $100 M against $77 M for Sight Sciences, Inc., both in the year to December 2025.
- Both made a net loss: $21 M for NeuroPace, Inc. and $38 M for Sight Sciences, Inc.
- NeuroPace, Inc. keeps more of each dollar of sales: a net margin of -21.5% against -49.7% for Sight Sciences, Inc.
- NeuroPace, Inc. employs more people: 209 against 186 at Sight Sciences, Inc. Each employee brings in about $478,421 of revenue at NeuroPace, Inc. and $415,914 at Sight Sciences, Inc.
- NeuroPace, Inc.'s revenue grew faster in its latest fiscal year: +25.1% against -3.1% for Sight Sciences, Inc.
- On the Piotroski F-score, a nine-point test of improving finances, NeuroPace, Inc. scores 5 and Sight Sciences, Inc. 5. Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | NeuroPace, Inc. NPCE · #12,651 in the world | Sight Sciences, Inc. SGHT · #13,037 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Founded | 1997 | 2010 |
| Size | ||
| Market cap | $487 M | $448 M |
| Revenue | $100 M | $77 M |
| Net income | $-21 M▲ best | $-38 M |
| Employees | 209 | 186 |
| Valuation | ||
| Price to sales | 4.8× | 5.1× |
| Price to book | 25.6× | 7.0× |
| Free cash flow yield | -2.3%▲ best | -6.7% |
| Profitability | ||
| Gross margin | 77.2% | 86.2%▲ best |
| Operating margin | -16.3%▲ best | -48.0% |
| Net margin | -21.5%▲ best | -49.7% |
| Return on equity | -158.7% | -50.8%▲ best |
| Growth | ||
| Revenue growth | 25.1%▲ best | -3.1% |
| Revenue growth, 3 years a year | 30.0%▲ best | 2.7% |
| Financial strength | ||
| Debt to equity | 3.1× | 0.7×▲ best |
| Interest cover | — | -7.2× |
| Cash | ||
| Free cash flow margin | -11.3%▲ best | -38.7% |
| Shareholder returns | ||
| Shareholder yield | 10.2% | — |
| Strength scores | ||
| Piotroski F-score | 5 of 9 | 5 of 9▲ best |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Sep 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
Questions and answers#
Which is bigger, NeuroPace, Inc. or Sight Sciences, Inc.?
NeuroPace, Inc. is the larger company by market value: $487 M against $448 M for Sight Sciences, Inc., 1.1 times as much (market caps of Sep 18, 2026 for NeuroPace, Inc. and Aug 1, 2026 for Sight Sciences, Inc.). NeuroPace, Inc.'s value is the last on file, from Sep 18, 2026: no market-data feed is connected for its exchange yet. Sight Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, NeuroPace, Inc. or Sight Sciences, Inc.?
NeuroPace, Inc. had more revenue: $100 M against $77 M for Sight Sciences, Inc., both in the year to December 2025. Both made a net loss: $21 M for NeuroPace, Inc. and $38 M for Sight Sciences, Inc.
Which is more profitable, NeuroPace, Inc. or Sight Sciences, Inc.?
NeuroPace, Inc. keeps more of each dollar of sales: a net margin of -21.5% against -49.7% for Sight Sciences, Inc.
Which has more employees, NeuroPace, Inc. or Sight Sciences, Inc.?
NeuroPace, Inc. employs more people: 209 against 186 at Sight Sciences, Inc. Each employee brings in about $478,421 of revenue at NeuroPace, Inc. and $415,914 at Sight Sciences, Inc.
Which is growing faster, NeuroPace, Inc. or Sight Sciences, Inc.?
NeuroPace, Inc.'s revenue grew faster in its latest fiscal year: +25.1% against -3.1% for Sight Sciences, Inc.
Which is financially stronger, NeuroPace, Inc. or Sight Sciences, Inc.?
On the Piotroski F-score, a nine-point test of improving finances, NeuroPace, Inc. scores 5 and Sight Sciences, Inc. 5. Both are in the distress zone of the Altman Z-score.